Treatment of Testicular Tumor & Clinical Evaluation of Tumor Marker.
- Author:
Heon Young KWON
1
;
Jin Han YOON
Author Information
1. Department of Urology, College of Medicine, Pusan National University, Pusan, Korea.
- Publication Type:Original Article
- Keywords:
tumor marker;
testicular tumor
- MeSH:
Adult;
Busan;
Carcinoma, Embryonal;
Child;
Choriocarcinoma;
Drug Therapy;
Endodermal Sinus Tumor;
Female;
Follow-Up Studies;
Humans;
Pregnancy;
Seminoma;
Survival Rate;
Teratoma;
Testicular Neoplasms
- From:Korean Journal of Urology
1986;27(1):103-110
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Treatment and clinical evaluation of tumor marker were made on 24 patients with testicular tumors, which were admitted to the Pusan National University Hospital From Jan. l970 to Dec. l984. There were 6 cases of infantile type embryonal carcinoma and 6 cases of teratoma in children. In adult, there were 5 cases of seminoma, 2 cases of embryonal carcinoma, 2 cases of teratoma, 1 case of choriocarcinoma, 1 case of yolk sac tumor and l case of seminoma with embryonal carcinoma. Over 2 years follow-up study was made on 19 cases. The results are summarized as follows: l. 2-year survival rate was 6l.1%. 2. After initiation of PVB chemotherapy for advanced testicular tumor since l982, survival rate was improved. 3. The rates of elevated AFP were high in advanced nonseminomatous testicular tumor, therefore the survival rates were poorer in patients with elevation of serum AFP. But the difference of the survival rates between AFP positive and negative patients diminished during the latest 3 years.
